Sign up to receive more information about YUTREPIA

Sign Up
Experience the power of prostacyclin delivered with ease Experience the power of prostacyclin delivered with ease

Experience the power of prostacyclin delivered with ease

YUTREPIA™ (treprostinil) inhalation powder is a unique prostacyclin therapy for patients with pulmonary arterial hypertension (PAH; WHO Group 1) and pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3). It was designed to deliver the medicine directly into the lungs, where it’s needed, with an easy-to-use, low-effort inhaler.

Unique

YUTREPIA is a unique therapy made using a novel technology to deliver the medicine where it matters.
Discover more

Easy to use

YUTREPIA is convenient and can be taken with ease, so it can fit into your daily schedule.
See the details

Proven

YUTREPIA can be tailored to meet your treatment goals.
Learn how

WHO = World Health Organization

References

  1. YUTREPIA. Prescribing information. Liquidia Technologies, Inc; 2025.